The Korean journal of internal medicine

  • 제29권1호
  • /
  • Pages.27-30
  • /
  • 2014
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

Third-generation cephalosporin resistance in gram-negative bacteria in the community: a growing public health concern

  • Park, Sun Hee (Division of Infectious Diseases, Department of Internal Medicine, Daejeon St. Mary's Hospital, The Catholic University of Korea College of Medicine)
  • 투고 : 2013.12.26
  • 심사 : 2013.12.28
  • 발행 : 2014.01.01
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008;8:159-166. https://doi.org/10.1016/S1473-3099(08)70041-0
  2. Park SH, Choi SM, Lee DG, et al. Emergence of extended-spectrum ${\beta}$-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes. Microb Drug Resist 2011;17:537-544. https://doi.org/10.1089/mdr.2011.0072
  3. Kang CI, Cha MK, Kim SH, et al. Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum ${\beta}$-lactamase-producing Escherichia coli over a 6-year period. J Korean Med Sci 2013;28:998-1004. https://doi.org/10.3346/jkms.2013.28.7.998
  4. Park SH, Byun JH, Choi SM, et al. Molecular epidemiology of extended-spectrum ${\beta}$-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15. BMC Infect Dis 2012;12:149. https://doi.org/10.1186/1471-2334-12-149
  5. Kanoksil M, Jatapai A, Peacock SJ, Limmathurotsakul D. Epidemiology, microbiology and mortality associated with community-acquired bacteremia in northeast Thailand: a multicenter surveillance study. PLoS One 2013;8:e54714. https://doi.org/10.1371/journal.pone.0054714
  6. Lee JA, Kang CI, Joo EJ, et al. Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum ${\beta}$-lactamase-producing Klebsiella pneumoniae. Microb Drug Resist 2011;17:267-273. https://doi.org/10.1089/mdr.2010.0134
  7. Lee S, Han SW, Kim KW, Song DY, Kwon KT. Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital. Korean J Intern Med 2014;29:49-56. https://doi.org/10.3904/kjim.2014.29.1.49
  8. Vardakas KZ, Tansarli GS, Rafailidis PI, Falagas ME. Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum ${\beta}$-lactamases: a systematic review and meta-analysis. J Antimicrob Chemother 2012;67:2793-2803. https://doi.org/10.1093/jac/dks301
  9. Kang CI, Song JH, Chung DR, et al. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli. Int J Antimicrob Agents 2010;36:284-287. https://doi.org/10.1016/j.ijantimicag.2010.05.009
  10. Rodriguez-Bano J, Navarro MD, Retamar P, et al. ${\beta}$-Lactam/${\beta}$-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum ${\beta}$-lactamase- producing Escherichia coli: a post hoc analysis of prospective cohorts. Clin Infect Dis 2012;54:167-174. https://doi.org/10.1093/cid/cir790

피인용 문헌

  1. Analysis of the third‐ and fourth‐generation cephalosporin use for the treatment of infections caused by Gram‐negative bacteria in hospital settings vol.70, pp.12, 2014, https://doi.org/10.1111/ijcp.12911
  2. Synergistic Effect of Doripenem and Cefotaxime to Inhibit CTX-M-15 Type β-Lactamases: Biophysical and Microbiological Views vol.8, pp.None, 2017, https://doi.org/10.3389/fphar.2017.00449
  3. Antimicrobial Resistance: a One Health Perspective vol.6, pp.2, 2014, https://doi.org/10.1128/microbiolspec.arba-0009-2017
  4. One Health—Its Importance in Helping to Better Control Antimicrobial Resistance vol.4, pp.1, 2019, https://doi.org/10.3390/tropicalmed4010022
  5. Molecular Interactions of Cephalosporins with the Deep Binding Pocket of the RND Transporter AcrB vol.123, pp.22, 2019, https://doi.org/10.1021/acs.jpcb.9b01351
  6. Levels of outpatient prescribing for four major antibiotic classes and rates of septicemia hospitalization in adults in different US states - a statistical analysis vol.19, pp.1, 2014, https://doi.org/10.1186/s12889-019-7431-8
  7. New marine-derived indolymethyl pyrazinoquinazoline alkaloids with promising antimicrobial profiles vol.10, pp.52, 2014, https://doi.org/10.1039/d0ra05319h
  8. Cephalosporin Resistance in Escherichia coli Isolated from Children with Septicemia in Mainland China from 2007 to 2017: A Systematic Review and Meta-Analysis vol.26, pp.10, 2014, https://doi.org/10.1089/mdr.2018.0368
  9. Effect of a “handshake” stewardship program versus a formulary restriction policy on High-End antibiotic use, expenditure, antibiotic resistance, and patient outcome vol.32, pp.7, 2020, https://doi.org/10.1080/1120009x.2020.1755589
  10. Antibiogram and beta-lactamase genes among cefotaxime resistant E. coli from wastewater treatment plant vol.9, pp.1, 2014, https://doi.org/10.1186/s13756-020-0702-4
  11. Clinical Outcomes of Ceftriaxone vs Penicillin G for Complicated Viridans Group Streptococci Bacteremia vol.8, pp.1, 2014, https://doi.org/10.1093/ofid/ofaa542
  12. Transcriptional expression of secondary resistance genes ccdB and repA2 is enhanced in presence of cephalosporin and carbapenem in Escherichia coli vol.21, pp.1, 2014, https://doi.org/10.1186/s12866-021-02136-y
  13. Improved detection of microbiological pathogens: role of partner and non-governmental organizations vol.21, pp.1, 2014, https://doi.org/10.1186/s12879-021-05999-8